Literature DB >> 185285

Prevalent serotypes of Bordetella pertussis in non-vaccinated communities.

N W Preston.   

Abstract

In many countries, the prevalent serotypes of Bordetella pertussis have changed from a mixture of types 1,2,3 and 1,2 (organisms possessing antigen 2) to a predominance of type 1,3. The timing of the change in different countries is shown to be related to the introduction of mass-vaccination with material rich in antigens 1 and 2 but weak in, or devoid of, antigen 3. In several parts of the world, there have been outbreaks of type 1,3 infection in fully vaccinated children. Non-vaccinated communities in various parts of the world still show the pattern of serotypes which existed elsewhere before mass-vaccination. In order to avoid the disappointments experienced in the past, it is essential that pertussis vaccine for use in previously non-vaccinated communities, like that for any other country, should be rich in each of the three antigens.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 185285      PMCID: PMC2129724          DOI: 10.1017/s0022172400055546

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  18 in total

1.  Antigenic modulation of Bordetella pertussis.

Authors:  B W LACEY
Journal:  J Hyg (Lond)       Date:  1960-03

2.  Pertussis agglutinins in vaccinated mice : difficulty in estimating the type-specific response.

Authors:  K C Agarwal; N W Preston
Journal:  Indian J Med Res       Date:  1976-03       Impact factor: 2.375

3.  Bordetella pertussis serotypes in a whooping cough outbreak.

Authors:  R V Aftandelians; J D Connor
Journal:  Am J Epidemiol       Date:  1974-05       Impact factor: 4.897

4.  Whooping cough in northern Israel.

Authors:  M Shmilovitz; N W Preston; H Zaltser; A Cahana
Journal:  Isr J Med Sci       Date:  1972-12

5.  Variation of serotype in strains of Bordetella pertussis.

Authors:  T N Stanbridge; N W Preston
Journal:  J Hyg (Lond)       Date:  1974-10

6.  The occurrence of Bordetella pertussis serotypes in Australia, 1950-1970.

Authors:  A C Blaskett; J Gulasekharam; L C Fulton
Journal:  Med J Aust       Date:  1971-04-10       Impact factor: 7.738

7.  Bordetella pertussis serotypes in the United States.

Authors:  G Eldering; J Holwerda; A Davis; J Baker
Journal:  Appl Microbiol       Date:  1969-10

8.  Protection by pertussis vaccine. Little cause for concern.

Authors:  N W Preston
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

9.  Pertussis agglutinins in vaccinated children: better response with adjuvant.

Authors:  N W Preston; R I Mackay; F N Bamford; J E Crofts; W L Burland
Journal:  J Hyg (Lond)       Date:  1974-08

10.  Experimental pertussis infection in the marmoset: type specificity of active immunity.

Authors:  T N Stanbridge; N W Preston
Journal:  J Hyg (Lond)       Date:  1974-04
View more
  9 in total

1.  Bordetella pertussis serotypes in Canada.

Authors:  S Toma; H Lo; M Magus
Journal:  Can Med Assoc J       Date:  1978-10-07       Impact factor: 8.262

Review 2.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

3.  Analysis of Bordetella pertussis populations in European countries with different vaccination policies.

Authors:  S C M van Amersfoorth; L M Schouls; H G J van der Heide; A Advani; H O Hallander; K Bondeson; C H W von König; M Riffelmann; C Vahrenholz; N Guiso; V Caro; E Njamkepo; Q He; J Mertsola; F R Mooi
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  The major fimbrial subunit of Bordetella pertussis binds to sulfated sugars.

Authors:  C A Geuijen; R J Willems; F R Mooi
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines.

Authors:  A C Blaskett; J C Cox
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

Review 6.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  A reappraisal of serotype factors 4, 5 and 6 of Bordetella pertussis.

Authors:  N W Preston; N Surapatana; E J Carter
Journal:  J Hyg (Lond)       Date:  1982-02

8.  Toxicity of pertussis vaccine.

Authors:  N W Preston
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-19

9.  Bordetella pertussis isolation in general practice: 1977-79 whooping cough epidemic in West Glamorgan.

Authors:  W Kwantes; D H Joynson; W O Williams
Journal:  J Hyg (Lond)       Date:  1983-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.